SynthesisFrontiers in pharmacology2026

Efficacy and safety of first- versus second-generation fibroblast growth factor receptor (FGFR) inhibitors in advanced or metastatic urothelial carcinoma with FGFR alterations: a systematic review and meta-analysis.

Zhe Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.